Latest news with #intelliAgent
Miami Herald
07-07-2025
- Business
- Miami Herald
Fathom Holdings and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / July 3, 2025 / RedChip Companies will air interviews with Fathom Holdings, Inc. (Nasdaq:FTHM) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, July 5, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S. Access the interviews in their entirety at: FTHM: In an exclusive interview, Marco Fregenal, CEO of Fathom Holdings, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the company's disruptive approach to real estate services through its proprietary, technology-driven platform. Fregenal highlights Fathom's flat-fee commission model, which empowers agents to retain more of their earnings while enabling industry-leading retention and rapid national expansion. With operations in 43 states and a network of over 14,700 agents, Fathom is scaling efficiently through its virtual model, integrated ancillary services, and strategic acquisitions, including the recent addition of My Home Group. He also addresses Fathom's innovative Bitcoin strategy and strong financial performance, including a 32% year-over-year revenue increase in Q1 2025, positioning the Company to capture additional market share amid an improving housing market. Pete O'Heeron, CEO of FibroBiologics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to spotlight the company's pioneering work in fibroblast-based cell therapies. O'Heeron discusses the advantages of fibroblasts over traditional stem cells, highlighting their regenerative and immunomodulatory properties, scalability, and safety profile. He outlines the Company's robust pipeline, led by CYWC628 for diabetic foot ulcers, which is slated to enter a Phase 1/2 clinical trial in Australia later this year. Additional programs, including CybroCell™ for degenerative disc disease and CYMS101 for multiple sclerosis, target multi-billion-dollar markets and are supported by promising preclinical and early human data. With over 240 issued and pending patents, a recently completed cGMP-compliant cell bank, and a seasoned leadership team, FibroBiologics is advancing a scalable, off-the-shelf platform poised to transform treatment for chronic diseases and deliver significant long-term value to shareholders. FTHM and FBLG are clients of RedChip Companies. Please read our full disclosure at About Fathom Holdings Inc. Fathom Holdings Inc. is a national, technology-driven real estate services platform integrating residential brokerage, mortgage, title, and SaaS offerings to brokerages and agents by leveraging its proprietary cloud-based software, intelliAgent. The Company's brands include Fathom Realty, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. For more information, visit About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit About RedChip Companies RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights. To learn more about RedChip's products and services, please visit: "Discovering Tomorrow's Blue Chips Today"™ Follow RedChip on LinkedIn: Follow RedChip on Facebook: Follow RedChip on Instagram: Follow RedChip on Twitter: Follow RedChip on YouTube: Follow RedChip on Rumble: Subscribe to our Mailing List: Contact: Dave GentryRedChip Companies Inc.1-407-644-4256info@ --END-- SOURCE: RedChip Companies, Inc. (Media Suite)
USA Today
03-07-2025
- Business
- USA Today
Fathom Holdings and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
RedChip Companies will air interviews with Fathom Holdings, Inc. (Nasdaq:FTHM) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, July 5, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S. Access the interviews in their entirety at: In an exclusive interview, Marco Fregenal, CEO of Fathom Holdings, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss the company's disruptive approach to real estate services through its proprietary, technology-driven platform. Fregenal highlights Fathom's flat-fee commission model, which empowers agents to retain more of their earnings while enabling industry-leading retention and rapid national expansion. With operations in 43 states and a network of over 14,700 agents, Fathom is scaling efficiently through its virtual model, integrated ancillary services, and strategic acquisitions, including the recent addition of My Home Group. He also addresses Fathom's innovative Bitcoin strategy and strong financial performance, including a 32% year-over-year revenue increase in Q1 2025, positioning the Company to capture additional market share amid an improving housing market. Pete O'Heeron, CEO of FibroBiologics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to spotlight the company's pioneering work in fibroblast-based cell therapies. O'Heeron discusses the advantages of fibroblasts over traditional stem cells, highlighting their regenerative and immunomodulatory properties, scalability, and safety profile. He outlines the Company's robust pipeline, led by CYWC628 for diabetic foot ulcers, which is slated to enter a Phase 1/2 clinical trial in Australia later this year. Additional programs, including CybroCell™ for degenerative disc disease and CYMS101 for multiple sclerosis, target multi-billion-dollar markets and are supported by promising preclinical and early human data. With over 240 issued and pending patents, a recently completed cGMP-compliant cell bank, and a seasoned leadership team, FibroBiologics is advancing a scalable, off-the-shelf platform poised to transform treatment for chronic diseases and deliver significant long-term value to shareholders. FTHM and FBLG are clients of RedChip Companies. Please read our full disclosure at About Fathom Holdings Inc. Fathom Holdings Inc. is a national, technology-driven real estate services platform integrating residential brokerage, mortgage, title, and SaaS offerings to brokerages and agents by leveraging its proprietary cloud-based software, intelliAgent. The Company's brands include Fathom Realty, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. For more information, visit About FibroBiologics Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit About RedChip Companies RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights. To learn more about RedChip's products and services, please visit: 'Discovering Tomorrow's Blue Chips Today'™ Follow RedChip on LinkedIn: Follow RedChip on Facebook: Follow RedChip on Instagram: Follow RedChip on Twitter: Follow RedChip on YouTube: Follow RedChip on Rumble: Subscribe to our Mailing List: Contact: Dave Gentry RedChip Companies Inc. 1-407-644-4256 info@ –END– SOURCE: RedChip Companies, Inc. (Media Suite) View the original press release on ACCESS Newswire
Yahoo
14-05-2025
- Business
- Yahoo
Fathom Holdings Inc (FTHM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
Total Revenue: $93.1 million, a 32.1% increase year over year. Brokerage Revenue: $88.9 million, up 36% from the previous year. Gross Profit: $8.1 million, a 13% increase year over year. Agent Count: Approximately 14,750, a 22.8% increase over Q1 2024. Real Estate Transactions: 9,715, a 26.1% increase compared to Q1 2024. Mortgage Revenue: $2.6 million, a 13% increase from Q1 2024. Title Revenue: $1 million, a 43% increase from Q1 2024. GAAP Net Loss: $5.6 million or $0.24 per share, compared to a loss of $5.9 million or $0.31 per share in Q1 2024. Adjusted EBITDA Loss: $1.5 million, unchanged from Q1 2024. Cash Position: $8 million at the end of the quarter. Warning! GuruFocus has detected 6 Warning Signs with FTHM. Release Date: May 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Fathom Holdings Inc (NASDAQ:FTHM) reported a 32.1% increase in total revenue for Q1 2025, reaching $93.1 million, exceeding analysts' expectations by 12%. Brokerage revenue climbed nearly 36% to $88.9 million, driven by increased transaction volume and agent count. The company successfully reduced expenses by approximately $750,000 per quarter, contributing to a more efficient and scalable business model. The new Elevate program, designed to enhance agent productivity and profitability, has already attracted over 120 agents since its soft launch. Fathom Holdings Inc (NASDAQ:FTHM) expects to achieve adjusted EBITDA profitability in the second quarter of 2025, marking a significant milestone in its financial performance. Despite revenue growth, Fathom Holdings Inc (NASDAQ:FTHM) reported a GAAP net loss of $5.6 million for Q1 2025, though this was an improvement from the previous year's loss. The company's technology segment saw a decrease in third-party revenues, dropping to $600,000 in Q1 2025 from $800,000 in Q1 2024. The mortgage business reported an adjusted EBITDA loss of $400,000, although this was an improvement from the previous year's loss. Verus Title, part of Fathom's title business, reported an adjusted EBITDA loss of $400,000 for Q1 2025, an increase from the previous year's loss. The company faces ongoing economic headwinds, including elevated mortgage rates and global economic uncertainty, which could impact future performance. Q: Can you elaborate on how the Elevate program enhances profitability on both gross profit and adjusted EBITDA per transaction compared to traditional programs? Also, what is the onboarding pipeline for agents into Elevate? A: Marco Fregenal, CEO, explained that Elevate charges a 20% commission split, and due to the efficiencies of the intelliAgent platform, they expect gross profit margins to grow by 3x to 4x compared to traditional margins. The program had a soft launch four weeks ago, with 120 agents already signed up. They aim to onboard about 100 new agents per month by the end of the year, with a careful approach to growth due to the program's complexity. Q: Outside of My Home Group, have there been discussions with other agent teams to join Fathom, and has the launch of Elevate accelerated these discussions? A: Marco Fregenal confirmed that the launch of Elevate has led to more conversations with brokerages and technology partners. They anticipate more partnerships and potential licensing agreements for Elevate in the coming months, with announcements expected within the next six months. Q: What impact do you expect Elevate to have on ancillary businesses? A: Marco Fregenal noted that Elevate could positively impact ancillary businesses by building closer relationships with participating agents. This could enhance margins, increase agent retention, and contribute to a more diverse revenue stream. Q: How has the market shift from a seller's market to a more balanced market affected Fathom's operations? A: Marco Fregenal mentioned that while mortgage rates remain elevated, they are stabilizing, and housing inventory is increasing. This shift has led to price reductions and longer market times, but Fathom is well-positioned to benefit from any market improvements due to their lean cost structure and value proposition. Q: Can you provide more details on the financial performance of the brokerage and ancillary businesses? A: Daniel Weinmann, VP of Finance, reported that brokerage revenue increased by 36% to $88.9 million, with a 26.1% increase in transactions. Mortgage revenue rose by 13% to $2.6 million, and title revenue increased by 43% to $1 million. These results were driven by strategic growth and cost-cutting initiatives. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
14-05-2025
- Business
- Yahoo
Fathom Holdings Inc (FTHM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
Total Revenue: $93.1 million, a 32.1% increase year over year. Brokerage Revenue: $88.9 million, up 36% from the previous year. Gross Profit: $8.1 million, a 13% increase year over year. Agent Count: Approximately 14,750, a 22.8% increase over Q1 2024. Real Estate Transactions: 9,715, a 26.1% increase compared to Q1 2024. Mortgage Revenue: $2.6 million, a 13% increase from Q1 2024. Title Revenue: $1 million, a 43% increase from Q1 2024. GAAP Net Loss: $5.6 million or $0.24 per share, compared to a loss of $5.9 million or $0.31 per share in Q1 2024. Adjusted EBITDA Loss: $1.5 million, unchanged from Q1 2024. Cash Position: $8 million at the end of the quarter. Warning! GuruFocus has detected 6 Warning Signs with FTHM. Release Date: May 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Fathom Holdings Inc (NASDAQ:FTHM) reported a 32.1% increase in total revenue for Q1 2025, reaching $93.1 million, exceeding analysts' expectations by 12%. Brokerage revenue climbed nearly 36% to $88.9 million, driven by increased transaction volume and agent count. The company successfully reduced expenses by approximately $750,000 per quarter, contributing to a more efficient and scalable business model. The new Elevate program, designed to enhance agent productivity and profitability, has already attracted over 120 agents since its soft launch. Fathom Holdings Inc (NASDAQ:FTHM) expects to achieve adjusted EBITDA profitability in the second quarter of 2025, marking a significant milestone in its financial performance. Despite revenue growth, Fathom Holdings Inc (NASDAQ:FTHM) reported a GAAP net loss of $5.6 million for Q1 2025, though this was an improvement from the previous year's loss. The company's technology segment saw a decrease in third-party revenues, dropping to $600,000 in Q1 2025 from $800,000 in Q1 2024. The mortgage business reported an adjusted EBITDA loss of $400,000, although this was an improvement from the previous year's loss. Verus Title, part of Fathom's title business, reported an adjusted EBITDA loss of $400,000 for Q1 2025, an increase from the previous year's loss. The company faces ongoing economic headwinds, including elevated mortgage rates and global economic uncertainty, which could impact future performance. Q: Can you elaborate on how the Elevate program enhances profitability on both gross profit and adjusted EBITDA per transaction compared to traditional programs? Also, what is the onboarding pipeline for agents into Elevate? A: Marco Fregenal, CEO, explained that Elevate charges a 20% commission split, and due to the efficiencies of the intelliAgent platform, they expect gross profit margins to grow by 3x to 4x compared to traditional margins. The program had a soft launch four weeks ago, with 120 agents already signed up. They aim to onboard about 100 new agents per month by the end of the year, with a careful approach to growth due to the program's complexity. Q: Outside of My Home Group, have there been discussions with other agent teams to join Fathom, and has the launch of Elevate accelerated these discussions? A: Marco Fregenal confirmed that the launch of Elevate has led to more conversations with brokerages and technology partners. They anticipate more partnerships and potential licensing agreements for Elevate in the coming months, with announcements expected within the next six months. Q: What impact do you expect Elevate to have on ancillary businesses? A: Marco Fregenal noted that Elevate could positively impact ancillary businesses by building closer relationships with participating agents. This could enhance margins, increase agent retention, and contribute to a more diverse revenue stream. Q: How has the market shift from a seller's market to a more balanced market affected Fathom's operations? A: Marco Fregenal mentioned that while mortgage rates remain elevated, they are stabilizing, and housing inventory is increasing. This shift has led to price reductions and longer market times, but Fathom is well-positioned to benefit from any market improvements due to their lean cost structure and value proposition. Q: Can you provide more details on the financial performance of the brokerage and ancillary businesses? A: Daniel Weinmann, VP of Finance, reported that brokerage revenue increased by 36% to $88.9 million, with a 26.1% increase in transactions. Mortgage revenue rose by 13% to $2.6 million, and title revenue increased by 43% to $1 million. These results were driven by strategic growth and cost-cutting initiatives. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
28-03-2025
- Business
- Yahoo
Is Fathom Holdings Inc. (FTHM) the Cheapest Stock Insiders Are Buying In March?
We recently published a list of . In this article, we are going to take a look at where Fathom Holdings Inc. (NASDAQ:FTHM) stands against other cheapest stocks insiders are buying in March. After solid gains Monday, the broader market index and blue chip companies traded flat Tuesday, while the NASDAQ Composite rose 0.2%. Monday's enthusiasm came from hopes of looser U.S. tariffs. Investors mostly ignored the March consumer confidence data released on Tuesday, which showed a sharp decline in U.S. consumers' short-term outlook on income, business, and job conditions, reports CNBC. 'Sentiment continues to wane among investors, consumers and businesses as economic concerns and economic policy uncertainty takes its toll,' said Bret Kenwell, U.S. investment analyst at eToro. 'Until there's more certainty on the tariff and macro front, sentiment and confidence remain vulnerable.' As investors navigate daily market changes, uncertainty remains a persistent factor. Insider trading tends to attract attention during these periods, as purchases of company stock by executives may suggest optimism about the company's future. However, insider selling doesn't necessarily signal a lack of confidence—it could simply be for personal financial reasons or to diversify holdings. Many executives use pre-established plans, such as 10b5-1, to maintain transparency. While insider trading can provide useful insights, it's important to evaluate it alongside a company's financial stability, broader market trends, and industry dynamics. What are some of the cheapest stocks insiders have been buying this month so far? To find out, we used Insider Monkey's insider trading stock screener, focusing only on stocks where at least two insiders had purchased shares in March. From there, we ranked the 10 stocks with the lowest average price per share. Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). With each stock, we note the average price per share of these purchases and the stock's market capitalization. Aerial view of a neighborhood with houses and a real estate brokerage office. Market Capitalization: $27.07 million Fathom Holdings is a real estate services platform that integrates residential brokerage, mortgage, title, and insurance services in the U.S. The Cary, North Carolina-based company operates in three segments: Real Estate Brokerage, Mortgage, and Technology, offering tools and services through its website and technology platform, intelliAgent. Fathom's brands include Fathom Realty, Dagley Insurance, Encompass Lending, and Verus Title. Fathom completed approximately 37,000 real estate transactions in 2024, marking a 2.2% decline compared to the previous year. Total revenue for 2024 decreased by 3%, totaling $335 million, down from $345 million in 2023. The GAAP net loss for 2024 was $21.6 million, or $1.07 per share, improving from a loss of $24.0 million, or $1.47 per share, in 2023, mainly due to cost-saving initiatives. The Adjusted EBITDA loss for 2024 was $5.7 million, compared to a loss of $4.1 million in 2023, driven by the 3% revenue reduction. Cash and cash equivalents as of December 31, 2024, decreased to $7.1 million from $7.4 million at the end of 2023. In March, two insiders bought nearly $600,000 worth of Fathom Holdings shares at an average price of $0.72 per share. Currently, the stock trades at $1.00 per share, having dropped 34.64% year-to-date and 50% over the past 12 months. According to MarketBeat, four analysts have given an average 'Buy' rating to Fathom stock with a price target of $4.25. The average price target suggests a potential upside of 325% from the latest price. Overall, FTHM ranks 9th on our list of cheapest stocks insiders are buying in March. While we acknowledge the potential of FTHM our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than FTHM but that trades at less than 5 times its earnings, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
